Lilly Appoints Philip Johnson to Senior Vice President and Treasurer

INDIANAPOLIS, November 13,2017 /PRNewswire/ --

Eli Lilly and Company (NYSE: LLY) today announced Philip Johnson has been appointed to senior vice president, Finance, and treasurer effective January 1, 2018. Johnson currently serves as vice president for Investor Relations at Lilly. He will report to Joshua Smiley, who will become senior vice president and chief financial officer effective January 1, 2018. Johnson will continue to lead Lilly's investor relations efforts.

     (Logo: https://mma.prnewswire.com/media/602604/ELI_LILLY_AND_COMPANY_LOGO.jpg )

"Phil has been a trusted partner for our shareholders, effectively communicating the company's results and expectations, while ensuring management's actions are informed by shareholder input," Smiley said. "With his external focus and experience in the capital markets, Phil is an ideal candidate to assume this important position and to help guide Lilly's financial strategy."

Johnson has been with Lilly 22 years, serving in a variety of financial roles in the U.S. and overseas. He has been in his current role since 2007 and before that was vice president, Finance, and chief financial officer for Global Manufacturing and Quality. Prior to joining Lilly, Johnson worked for six years in investment banking and management consulting in the U.S. and Europe.

About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and http://newsroom.lilly.com/social-channels. C-LLY

Refer to: Mark Taylor; mark.taylor@lilly.com; 317-276-5795

This is a disclosure announcement from PR Newswire.